Pacira BioSciences Inc. (PCRX) Statistics & Valuation Metrics - Stocknear

Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
26.05
-0.16 (-0.61%)
At close: Sep 24, 2025, 3:59 PM
26.05
0.00%
After-hours: Sep 24, 2025, 04:20 PM EDT

Pacira BioSciences Statistics

Share Statistics

Pacira BioSciences has 44.93M shares outstanding. The number of shares has increased by 0.39% in one year.

44.93M
0.39%
0.06%
99.99%
39.82M
138
0.02%

Short Selling Information

The latest short interest is 6.61M, so 14.71% of the outstanding shares have been sold short.

6.61M
14.71%
21.09%
10.87

Valuation Ratios

The PE ratio is -8.75 and the forward PE ratio is 8.04. Pacira BioSciences's PEG ratio is 0.03.

-8.75
8.04
1.24
1.4
1.12
4.87
0.03
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Pacira BioSciences.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 2.4, with a Debt / Equity ratio of 0.82.

2.4
2
0.82
21.94
3.57
-4.43

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$889.55K
$-126.35K
788
0.45
1.36

Taxes

36.45M
-57.77%

Stock Price Statistics

The stock price has increased by 87.28% in the last 52 weeks. The beta is 0.42, so Pacira BioSciences's price volatility has been higher than the market average.

0.42
87.28%
24.76
24.1
50
664,252

Income Statement

In the last 12 months, Pacira BioSciences had revenue of 700.97M and earned -99.56M in profits. Earnings per share was -2.15.

700.97M
530.54M
-73.37M
-99.56M
29.12M
-49.67M
-2.15
Full Income Statement

Balance Sheet

The company has 276.77M in cash and 638.85M in debt, giving a net cash position of -362.08M.

276.77M
638.85M
-362.08M
-206.36M
1.54B
432.45M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 189.39M and capital expenditures -10.64M, giving a free cash flow of 178.75M.

189.39M
-10.64M
178.75M
3.87
Full Cash Flow Statement

Margins

Gross margin is 75.69%, with operating and profit margins of -10.47% and -14.2%.

75.69%
-10.47%
-9%
-14.2%
4.15%
-10.47%
25.5%

Dividends & Yields

PCRX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for PCRX is $24.5, which is -6% lower than the current price. The consensus rating is "Buy".

$24.5
-6%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

1.29
6